Finance

Lists
Q3 2026 earnings • released • EPS beat +37.07% • Revenue beat +10.80%
See results
SPNT:NYSE
Siriuspoint Ltd
$26.41
+0.30%
(+0.080) 1D
$26.41
0.00% (0.00)
After hours
Closed: Nov 9, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPNT...
Open
$26.39
High
$26.68
Low
$25.44
Mkt. cap
3.07B
Avg. vol.
807.89K
Volume
989.87K
P/E ratio
6.67
52-wk high
$27.12
52-wk low
$19.15
EPS
$3.96
Beta
0.60
Shares outstanding
115.03M
No. of employees
1K
Open
$26.39
High
$26.68
Low
$25.44
Mkt. cap
3.07B
Avg. vol.
807.89K
Volume
989.87K
P/E ratio
6.67
52-wk high
$27.12
52-wk low
$19.15
EPS
$3.96
Beta
0.60
Shares outstanding
115.03M
No. of employees
1K
News stories
From web sources and news partners
About Siriuspoint Ltd
CEOScott Egan
Employees1.07K
Founded2011
Headquarters-
SectorFinancials
IndustryInsurance
Analyst ratings
Based on 2 analysts giving stock ratings to SPNT in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SPNT in the last 3 months.
Highest
Current $26.41
$30.00 (+13.59%)
Average
$28.50 (+7.91%)
Lowest
$27.00 (+2.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Phillips CFA
Oppenheimer
Buy
Maintained
$27.00
+2.2%
10/13/2026
Rowland Mayor
RBC Capital
Buy
Maintained
$30.00
+13.6%
10/12/2026
Gregory Peters
Raymond James
Hold
Reiterated
-
-
05/28/2026
Timothy D'Agostino
B. Riley Securities
Buy
Initiated
$31.00
+17.4%
04/17/2026
Last report
Nov 6, 2026
Fiscal period
Q3 2026
$0.88 / $0.64
+37.07%beat
Revenue / Est. (USD)
867.60M / 783.07M
+10.80%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
762.30M
749.40M
744.10M
867.60M
Cost of goods sold
600.30M
561.20M
566.80M
664.10M
Cost of revenue
600.30M
561.20M
566.80M
664.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.00M
71.20M
73.70M
75.70M
Operating expense
65.40M
73.80M
76.10M
78.20M
Total operating expenses
665.70M
635.00M
642.90M
742.30M
Operating income
96.60M
114.40M
101.20M
125.30M
Other non operating income
-
-
-
-
EBT including unusual items
280.20M
121.50M
84.30M
103.70M
EBT excluding unusual items
68.80M
96.30M
84.30M
103.70M
Income tax expense
36.10M
19.20M
15.80M
16.70M
Effective tax rate
12.88%
15.80%
18.74%
16.10%
Other operating expenses
-
-
-
-
Net income
244.00M
102.20M
68.60M
86.80M
Net profit margin
32.01%
13.64%
9.22%
10.00%
Earnings per share
0.70
0.70
0.67
0.88
Interest and investment income
-
-
-
-
Interest expense
-19.50M
-16.80M
-18.70M
-18.40M
Net interest expenses
-19.50M
-16.80M
-18.70M
-18.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
99.00M
117.00M
103.60M
127.80M
Gain or loss from assets sale
-222.40M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps